94228_06_Pfizer_Proposals_BM.qxp_06 3/5/20 6:31 PM Page vi

Corporate and Shareholder Information

STOCK LISTING SHAREHOLDER SERVICES AND PROGRAMS The principal market for our Common Stock is the New York Please contact our Stock Transfer Agent and Registrar, Stock Exchange and our stock is also traded on various Computershare, with inquiries concerning shareholder United States regional stock exchanges. accounts of record and stock transfer matters and for information on the following services and programs: STOCK TRANSFER AGENT AND REGISTRAR • Computershare Investment Plan Computershare Investor Services - direct purchase of Pfizer stock P.O. Box 505000 - dividend reinvestment Louisville, KY 40233-5000 - automatic monthly or bi-monthly investments Telephone: 1-800-733-9393 • Book-entry share ownership Outside the U.S., Canada and Puerto Rico: 1-781-575-4591 • Direct deposit of dividends Internet: www.computershare.com/investor

FORM 10-K Upon written request, we will provide, without charge, a copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019. Requests should be directed to: Corporate Secretary Pfizer Inc. 235 East 42nd Street New York, NY 10017 Our Form 10-K is also available on our website at www.pfizer.com.

EXECUTIVE LEADERSHIP TEAM Albert Bourla, DVM, Ph.D. Chairman and Chief Executive Officer Frank A. D’Amelio Chief Financial Officer, Executive Vice President, Business Operations and Global Supply Mikael Dolsten, M.D., Ph.D. Chief Scientific Officer, President, Worldwide Research, Development and Medical Lidia Fonseca Chief Digital and Technology Officer, Executive Vice President Angela Hwang Group President, Pfizer Biopharmaceuticals Group Rady A. Johnson Chief Compliance, Quality and Risk Officer, Executive Vice President Douglas M. Lankler General Counsel, Executive Vice President A. Rod MacKenzie, Ph.D. Chief Development Officer, Executive Vice President Dawn Rogers Chief Human Resources Officer, Executive Vice President Sally Susman Chief Corporate Affairs Officer, Executive Vice President John D. Young Chief Business Officer, Group President